Around 40 Cases Of Delta Plus “Variant Of Concern” Found In India.

Share:

Around 40 Cases Of Delta Plus “Variant Of Concern” Found In India.

Delta Plus cases, still a low number, are emerging as large parts of India are ending severe lockdowns and restrictions with Covid cases on the decline after a fierce second wave ambushed the nation’s health infrastructure in April-May.

INSACOG (Indian SARS-CoV-2 Genomic Consortia), a consortium of 28 labs tasked with genome sequencing of the virus causing Covid, says properties of the Delta Plus are still being investigated. It is characterized by a mutation in the spike protein, which helps the virus gain entry into human cells.

“Currently the number of such Delta plus variants in India are only few but the distribution/detection in various states during past two months indicate that it is already present in some states and states may need to enhance their public health response by focusing on surveillance, enhanced testing, quick contact-tracing and priority vaccination,” it says.

According to the government’s advisory on Tuesday, Delta Plus cases have been found in Maharashtra’s Ratnagiri and Jalgaon; in Palakkad and Pathanamthitta in Kerala; and in Bhopal and Shivpuri in Madhya Pradesh.

Maharashtra says it is collecting data like travel history and vaccination status of those who have reported this version of the virus.

“The Centre has sent an advisory to these states about their public health response. The measures, while broadly remaining the same as have been implemented by them earlier, have to become more focused and effective. We don’t want this small number to take a bigger form,” VK Paul, the head of the National Expert Group on Vaccine Administration, told reporters.

Very little is known about this strain, which is now in nine countries – US, UK, Portugal, Switzerland, Japan, Poland, Russia and China besides India.

According to the government, the Delta Plus, much like the Delta strain that has spread to 80 countries, is highly infectious and fast-spreading.

According to INSACOG, the Delta Plus shows “increased transmissibility, stronger binding to receptors of lung cells and potentially reduced monoclonal antibody response”.

It may also show resistance to existing treatment protocol for Covid, experts worry. There are concerns over whether current vaccines will be effective against the Delta Plus.

The government said while the two vaccines being used in India, Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin, are effective against the Delta variant, data on how they work on the Delta Plus would be shared later.

Join WhatsApp Group Click Here
Join Telegram Group Click Here
Follow on Facebook Click Here
Follow on Instagram Click Here
Follow on Twitter Click Here
Subscribe on YouTube Click Here
Share:

Leave a Comment